Evaluating the effect of trans cranial direct current stimulation on myasthenia gravis
Phase 2
- Conditions
- Myasthenia gravis.Myasthenia gravisG70.0
- Registration Number
- IRCT20181109041598N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
patients who were diagnosed through medical criteria and laboratory tests were referred by a neurologist
patients who were under MG treatment for at least 3 months prior to the study.
under the medication with or without thymectomy
The average age is 18 to 40 years old
Exclusion Criteria
Being pregnant
psychological or neurological disorders
MG crisis for at least 3 month prior to the study
Having unsightly sleep on the night before the test and having a high fatigue on the day of the test
Any history of consuming nicotine and substance abuse
using caffeine in less than 5 hours
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Muscular function of myasthenia gravis. Timepoint: In two rounds of the first and second sessions. Method of measurement: Quantitative Myasthenia Gravis (QMG)for Quantitative Measurement of Disease Symptoms, mannual mucle testing (MMT) for measuring muscle strength and MG-QOL15 (myasthenia gravis quality of life) for assessing the quality of life of a person with MG.
- Secondary Outcome Measures
Name Time Method